Started phase II. 1  JX-594, by Jennerex, is currently in phase II for hepatocellular carcinoma. 2  Seneca Valley virus (NTX-010) and (SVV-001), oncolytic picornavirus, is in phase II for small cell lung cancer and neuroblastoma. 3  ColoAd1 was developed by Psioxus Therapeutics Ltd using the process of directed evolution.